Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the feasibility, safety, and efficacy of psychotherapy-assisted psilocybin for severe obsessive-compulsive disorder; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Obsessive-compulsive Disorder | Phase 2 | Status: RECRUITING